Background The PATINA trial tested whether adding palbociclib to standard maintenance therapy improves outcomes in HR+/HER2+ metastatic breast cancer—a biologically…
Here is our 5-level Oncology Heat Index using chili pepper emojis to rate how ‘hot/important’ each post is with regards…
The Bottom Line The Phase 3 RECITE trial demonstrates that in patients with gastrointestinal cancers and persistent chemotherapy-induced thrombocytopenia (CIT),…
The Bottom Line The COBRRA trial provides the first head-to-head randomized comparison of apixaban versus rivaroxaban in acute VTE, demonstrating…
Immunotherapy Tox Management
Bispecific Toxicity Management
chriszacht